AGA临床实践更新:成人炎症性肠病住院管理专家综述
美国胃肠病协会(AGA)发布住院成人炎症性肠病(IBD)管理专家综述,围绕13个关键临床问题提出最佳实践建议,涵盖住院指征、初始评估与支持治疗、静脉激素方案、巨结肠手术评估、生物制剂拯救治疗、克罗恩病梗阻与脓肿处理及出院过渡计划。
要点
- 重度溃疡性结肠炎住院首选用静脉甲泼尼龙60 mg/日等效剂量,72小时内评估应答。
- 住院IBD患者应接受静脉血栓栓塞预防性抗凝,并评估并发症与合并感染。
- 重度UC需早期外科会诊并告知结肠切除可能,未应答激素者准备拯救治疗。
核心结论
- 住院成人IBD管理需综合评估疾病活动、并发症和感染,及时启动激素或拯救治疗并规划出院过渡。
研究设计与样本
- AGA临床实践更新委员会委托并批准的专家综述,基于文献回顾和专家意见提出13条最佳实践建议,未进行系统评价,无正式证据等级。
主要发现
- 住院IBD患者常出现医院获得性并发症、手术延迟和30天再入院率高,提示住院管理存在差异。
- 重度UC住院患者应静脉使用甲泼尼龙60 mg/日等效剂量,并在72小时内监测治疗反应。
- 克罗恩病合并腹腔脓肿需根据大小和位置行脓肿引流并联合全身抗生素。
关键数值与推荐
- 最佳实践建议7:重度UC住院患者初始治疗为静脉甲泼尼龙60 mg/日等效剂量。
- 最佳实践建议8:重度UC住院患者应在开始治疗72小时内监测治疗反应。
- 最佳实践建议5:住院IBD患者应接受预防性抗凝以预防静脉血栓栓塞。
- 最佳实践建议13:出院前应达到治疗反应稳定并建立清晰的出院过渡计划。
临床怎么用
- 对门诊治疗无效、怀疑肠梗阻或腹腔脓肿、或存在显著营养风险的成人IBD患者应考虑及时住院。
- 住院初始管理包括支持治疗、评估IBD相关并发症和合并感染,并按指征用生物标志物和内镜评估疾病活动。
- 重度UC应早期外科会诊并告知结肠切除可能,激素无应答者准备拯救治疗。
- 克罗恩病合并肠梗阻且证据显示活动性炎症时可考虑静脉激素治疗。
局限性
- 本专家综述未进行系统评价,最佳实践建议不附带正式的证据质量或推荐强度分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DESCRIPTION: Patients with inflammatory bowel disease (IBD) often require hospitalization for medically refractory IBD or IBD-related complications. However, despite the increasing availability of effective medical therapies, inpatient IBD care remains challenging, as evidenced by the variation in hospital-acquired complications, delays in surgery, and high 30-day readmission rates. Therefore, this Clinical Practice Update Expert Review is intended to provide Best Practice Advice on the evaluation and management of hospitalized adult patients with IBD. We have developed Best Practice Advice statements to address 13 key clinical issues. METHODS: This Expert Review was commissioned and approved by the American Gastroenterological Association (AGA) Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the AGA Institute Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. These Best Practice Advice statements were drawn from a review of the published literature and from expert opinion. Because systematic reviews were not performed, these Best Practice Advice statements do not carry formal ratings of the quality of evidence or strength of the presented considerations. Best Practice Advice Statements BEST PRACTICE ADVICE 1: Prompt hospitalization should be considered for adult patients with IBD who present with severe disease refractory to outpatient treatment when there is high suspicion for an IBD-related complication, such as intestinal obstruction or intra-abdominal abscess, or when there is significant nutritional risk or failure to thrive. BEST PRACTICE ADVICE 2: The initial management of hospitalized adult patients with IBD should include supportive care. BEST PRACTICE ADVICE 3: The initial management of hospitalized adult patients with IBD should include an evaluation for IBD-related complications and concomitant infections. BEST PRACTICE ADVICE 4: Hospitalized adult patients with IBD should have their disease activity assessed with both biomarkers and endoscopic evaluation, when indicated. BEST PRACTICE ADVICE 5: Hospitalized adult patients with IBD should receive prophylactic anticoagulation for prevention of venous thromboembolism. BEST PRACTICE ADVICE 6: Hospitalized adult patients with severe ulcerative colitis should be counseled on the potential need for colectomy and should have a timely referral for surgical consultation. BEST PRACTICE ADVICE 7: Hospitalized adult patients with severe ulcerative colitis should receive initial treatment with intravenous corticosteroids at a methylprednisolone 60-mg daily dose equivalent. BEST PRACTICE ADVICE 8: Hospitalized adult patients with severe ulcerative colitis should be monitored for treatment response within 72 hours of medical treatment initiation. BEST PRACTICE ADVICE 9: Preparations should be made for initiating rescue therapy in hospitalized adult patients with severe ulcerative colitis who are not responsive to intravenous corticosteroid treatment. BEST PRACTICE ADVICE 10: In hospitalized adult patients with Crohn's disease and intestinal obstruction, medical treatment with intravenous corticosteroids should be considered when there is evidence of active inflammation. BEST PRACTICE ADVICE 11: In hospitalized adult patients with Crohn's disease and an intra-abdominal abscess, treatment should include infection control with abscess drainage (depending on size and location) and systemic antibiotics, as well as decision making regarding further medical or surgical management. BEST PRACTICE ADVICE 12: Hospitalized adult patients with Crohn's disease and active perianal symptoms should have a multidisciplinary treatment approach involving both medical and surgical care. BEST PRACTICE ADVICE 13: Stability of treatment response should be achieved before discharge, and a clear discharge transition plan established.
引用
- Cohen-Mekelburg S, Hashash JG, Loftus EV, et al. AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review. Gastroenterology. 2026. PMID: 41579011. doi:10.1053/j.gastro.2025.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。